Serum SAMD9 as a Potential Prognostic Biomarker for Pancreatic Cancer
Simple Summary Pancreatic cancer remains one of the deadliest malignancies, and effective biomarkers for its detection and prognosis are still lacking. In this study, SAMD9 was consistently overexpressed in pancreatic cancer tissues and was associated with poor patient outcomes. Analyses of public datasets showed that...